Related Experiment Videos
Immunotherapy in autoimmune diseases.
A Miller1, D A Hafler, H L Weiner
1Brigham and Women's Hospital, Boston, Massachusetts.
Current Opinion in Immunology
|December 1, 1991
Summary
Understanding T-cell activation and immunological tolerance has advanced, focusing on the trimolecular complex. This knowledge is key for developing new immunotherapies for autoimmune diseases.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Significant advancements in understanding immunological tolerance to self-antigens.
- Progress in elucidating the genetic and molecular basis of T-cell recognition and activation.
Purpose of the Study:
- To investigate the trimolecular complex (antigen, MHC, TCR) as a target for immune intervention.
- To explore new immunomodulatory therapeutic approaches for autoimmune diseases.
Main Methods:
- Utilizing animal models of autoimmune diseases (spontaneous and induced).
- Focusing on the trimolecular complex as a therapeutic target.
Main Results:
- Demonstrated progress in understanding T-cell recognition and activation pathways.
- Identified potential for new immunomodulatory strategies.
Conclusions:
- The trimolecular complex serves as a viable target for immune intervention in autoimmune diseases.
- Emerging immunotherapies show promise for treating human autoimmune conditions.